Predictors of pulmonary exacerbation treatment in cystic fibrosis

BACKGROUND: Most studies of pulmonary exacerbations (PEx) in cystic fibrosis (CF) focus on intravenous (IV)-treated PEx, though most PEx are treated with oral antibiotics. Our objectives were to describe predictors of antibiotic choice and outcomes for PEx initially identified in clinic. METHODS: Fo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cyst Fibros
Egile Nagusiak: Sanders, Don B., Ostrenga, Joshua S., Rosenfeld, Margaret, Fink, Aliza K., Schechter, Michael S., Sawicki, Gregory S., Flume, Patrick A., Morgan, Wayne J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6940539/
https://ncbi.nlm.nih.gov/pubmed/31257102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2019.06.008
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak